Results 261 to 270 of about 8,174,546 (314)

Compliance during treatment with antidepressants

Journal of Affective Disorders, 1997
Compliance has become a topic of intense investigation and debate during the past two decades. The present review first examines to what factors the exponential increase in research studies on the topic can be attributed. A second part summarizes the history of the concept, the definitions and measurements of compliance and the estimations of ...
Koen Demyttenaere
exaly   +3 more sources

Compliance with antipsychotic treatment

Acta Psychiatrica Scandinavica, 2000
Objective: Despite the demonstrated efficacy of antipsychotics the relapse rate among patients with schizophrenia remains high. One major reason for this is non‐compliance. In this article we review different factors influencing compliance and discuss possibilities to enhance compliance among schizophrenic patients.
M, Oehl, M, Hummer, W W, Fleischhacker
openaire   +2 more sources

Compliance with Topical Pilocarpine Treatment

American Journal of Ophthalmology, 1986
Using an unobtrusive eyedrop medication monitor, we measured compliance with topical pilocarpine treatment in a sample of 184 patients. The eyedrop monitor recorded electronically the date and time of each pilocarpine administration over a four- to six-week period. The subjects administered a mean +/- S.D.
M A, Kass, D W, Meltzer, M, Gordon, D, Cooper, J, Goldberg   +4 more
openaire   +4 more sources

Compliance With Topical Timolol Treatment

American Journal of Ophthalmology, 1987
To determine if compliance with timolol treatment was better than compliance with pilocarpine treatment (as reported previously), we measured compliance with timolol treatment in a sample of 110 patients using an unobtrusive eyedrop medication monitor, which recorded electronically the date and time of each drug administration over a four- to six-week ...
M A, Kass, M, Gordon, R E, Morley, D W, Meltzer, J J, Goldberg   +4 more
openaire   +2 more sources

COMPLIANCE TO TREATMENT IN HYPERTENSION

2008
[No abstract available]
Erdine, Serap, Viigimaa, Margus
openaire   +2 more sources

Compliance with treatment of rheumatoid arthritis

Rheumatology International, 2011
Rheumatoid arthritis (RA) is a chronic, progressive, debilitating disease that demands continuous therapy with multiple medications. Noncompliance with disease-modifying drugs may cause disease flares, preventable functional impairment, unnecessary treatment changes, and loss of health care resources.
Raili, Müller, Riina, Kallikorm, Kaja, Põlluste, Margus, Lember   +3 more
openaire   +2 more sources

Compliance with disulfiram treatment of alcoholism

Journal of Chronic Diseases, 1983
One hundred twenty-four men were randomly assigned to receive disulfiram with a riboflavin marker or riboflavin alone. During a one year follow-up urine specimens were collected at each visit and analyzed for riboflavin. There was a strong relationship between excellent attendance and infrequent drinking. For subjects taking disulfiram there was a high
R, Fuller, H, Roth, S, Long
openaire   +2 more sources

Compliance with treatment for osteoporosis

The Lancet, 2006
Juliet Compston and Ego Seeman (Sept 16, p 973) highlight poor compliance with therapy in postmenopausal osteo porosis. They state that com pliance is improved with weekly, compared with daily, bisphosphonates, but that overall compliance and persistence rates remain unsatisfactory.
openaire   +2 more sources

Compliance During Treatment of Epilepsy

Epilepsia, 1988
Summary: Noncompliance is a major factor in suboptimal control of epileptic seizures. As many as one‐third to one‐half of persons with epilepsy may be noncompliant. Noncompliance negates the usefulness of the advances made in the diagnosis and treatment of epilepsy and is perhaps the single most important factor in increasing the costs of care for ...
openaire   +2 more sources

Compliance Issues in Outpatient Treatment

Journal of Clinical Psychopharmacology, 1985
Estimated compliance rates of 40 to 50% are common among psychiatric outpatients. Likely noncompliers in the acute phase of illness include manic patients, paranoid schizophrenics, and the profoundly depressed. Noncompliance during the long-term prophylactic or maintenance treatment phase tends to increase with the passage of time.
openaire   +2 more sources